Immune response to ferredoxin; nonresponder status is not due to suppression
- PMID: 6208265
Immune response to ferredoxin; nonresponder status is not due to suppression
Abstract
Ferredoxin (Fd), a small protein from Clostridium pasteurianum, has been selected for immunologic studies because of its limited number (two) of antigenic determinants. Functionally (as determined by antibody binding), monodeterminant fragments of Fd can be generated enzymatically, leaving molecules only a few amino acids smaller than the native protein, with unaltered solid phase binding properties. These fragments were used to assess the immune response to each of the two determinants. Clear differences in immunologic properties can be assigned to sequences within Fd: the amino terminal tripeptide is responsible for inducing a proliferative response and limited antibody production, whereas the carboxy terminal dipeptide accounts for most of the antibody activity, yet little, if any, T-proliferative activity. Studies with the enzyme-generated fragments of Fd have unmasked a sequence proximal to the amino terminal that represents a second determinant for T cell proliferation but does not have any demonstrable antibody-inducing activity. This third determinant is shown to induce responsiveness to Fd in nonresponder animals after the removal of the amino terminal tripeptide. The results indicate that nonresponsiveness to this molecule in H-2d mice is not a direct effect of suppression.
Similar articles
-
Abrogation and reconstitution of nonresponsiveness: a correlation with high network connectivity.Eur J Immunol. 1985 May;15(5):526-9. doi: 10.1002/eji.1830150519. Eur J Immunol. 1985. PMID: 3158533
-
Genetic control of the immune response to ferredoxin: linkage and mapping of T cell proliferation and antibody production genes to the MHC of mice.J Immunol. 1980 Jun;124(6):2615-9. J Immunol. 1980. PMID: 6768798
-
Ir gene control of immune responses to insulins. II. Phenotypic differences in T cell activity among nonresponder strains of mice.J Immunol. 1983 May;130(5):2062-6. J Immunol. 1983. PMID: 6187834
-
Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.J Mol Recognit. 1993 Jun;6(2):81-94. doi: 10.1002/jmr.300060206. J Mol Recognit. 1993. PMID: 7508238
-
The distinctive specificity of antigen-specific suppressor T cells.Immunol Today. 1991 Apr;12(4):111-8. doi: 10.1016/0167-5699(91)90094-A. Immunol Today. 1991. PMID: 1711854 Review.